Chennai, May 21:
EGS Health has announced the launch of Medicas Comprehensive Cancer Care (MC3), a nationwide platform aimed at improving access to expert-led cancer treatment guidance and coordinated care across India.
The platform offers second opinions, multidisciplinary oncology support, and end-to-end care coordination—from early detection to recovery—while also focusing on emotional support for patients. Backed by a panel of national and international oncologists, MC3 seeks to bridge gaps in specialised cancer care, especially in Tier 2 and Tier 3 cities where access to advanced expertise remains limited.
Designed as a human-led service, MC3 enables collaborative decision-making involving patients, their primary doctors, and a team of specialists. It provides guidance across precision oncology, rehabilitation, psycho-oncology, and palliative care, helping patients navigate complex treatment pathways with greater clarity.
EGS Group said the platform adheres to global data privacy standards, including HIPAA and GDPR protocols, ensuring secure handling of patient information while delivering personalised, expert-driven cancer care solutions.